Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rusen Zhao"'
Publikováno v:
Water, Vol 16, Iss 21, p 3041 (2024)
Steel jacking pipes are potentially prone to buckling instability, a phenomenon that has received limited attention in hard rock formations. This study reports on the field monitoring of a water pipeline project in Zhongshan City, where the circumfer
Externí odkaz:
https://doaj.org/article/9fac6caf43f4422f8f7c7973bcc979fb
Autor:
Jieqiong Liu, Chuangui Song, Xiangcai Wang, Mingli Ni, Xujuan Wang, Lei Chen, Hongwei Yang, Rusen Zhao, Ting Xu, Lin Shen
Publikováno v:
Cancer Research. 82:P5-16
Background: HER2-targeted therapies combined with chemotherapy have improved survival outcomes for patients with metastatic HER2-positive breast cancer. However, for patients progressed after several lines of anti-HER2 combinational therapies, the ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffb665371e3133ab6d2fd81aa9331728
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-04
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-04
Autor:
Jianming Xu, Jieer Ying, Rongrui Liu, Jun Wu, Feng Ye, Nong Xu, Yanqiao Zhang, Rusen Zhao, Xiaojun Xiang, Jianhong Wang, Xiaoyan Lin, Huiting Xu, Shegan Gao, Suxia Luo, Baohong Guo, Xionghui Li, Yangzhi Su, Qian Wang
Publikováno v:
European journal of cancer (Oxford, England : 1990). 178
KN026 is a novel human epidermal growth factor receptor 2 (HER2)-targeted bispecific antibody that binds two distinct domains of HER2. We report the safety and efficacy results of the phase 2 trial in patients with advanced HER2-expressing gastric or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c15802c79df3231ac330d6fbf2da0b4
https://pubmed.ncbi.nlm.nih.gov/36370604
https://pubmed.ncbi.nlm.nih.gov/36370604
Autor:
Jianming Xu, Rongrui Liu, Jieer Ying, Jun Wu, Feng Ye, Nong Xu, Yanqiao Zhang, Rusen Zhao, Xiaojun Xiang, Jianhong Wang, Xiaoyan Lin, Huiting Xu, Shegan Gao, SuXia Luo, Baohong Guo, Xionghui Li, Yangzhi Su, Qian Wang
Publikováno v:
Journal of Clinical Oncology. 40:4040-4040
4040 Background: Outcomes of second or later-line treatment for pts with advanced GC/GEJC remain inferior. KN026 is a novel HER2-targeted bispecific antibody composed of VH regions of trastuzumab and pertuzumab, targeting the HER2 juxtamembrane domai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ef2362d8dea548bdbd1af63a97eca75
https://doi.org/10.1200/jco.2022.40.16_suppl.4040
https://doi.org/10.1200/jco.2022.40.16_suppl.4040
Autor:
Ningling Zhang, Zengjun Li, Yulan Gu, Jun Yan, Jun Ma, Yong Chen, Gang Cheng, Rusen Zhao, Zhangxia Ren, Huiqiang Huang, Haijiao Yan, Gao Yan, Guifang Zhang, Zhengxiang Han, Xiaoguang Wang, Weie Zheng, Zhihua Yao
Publikováno v:
Blood. 138:4569-4569
Background: Neutropenia is a frequently reported adverse event in patients with hematologic malignancies. Prophylactic administration of long-acting granulocyte colony stimulating factor(G-CSF) had been widely applied in different solid tumors. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46b56b86396c23b792c55185aeebb990
https://doi.org/10.1182/blood-2021-149884
https://doi.org/10.1182/blood-2021-149884
Autor:
Jun Wu, Feng Ye, Qiong Wu, Xiaojun Xiang, Juan Liu, Ting Xu, Shuning Xing, Rusen Zhao, Yun Zhang, Yanqiao Zhang, Jianming Xu, Baohong Guo, Yuchen Liu, Jieer Ying, Nong Xu, Jianhong Wang
Publikováno v:
Journal of Clinical Oncology. 39:e16005-e16005
e16005 Background: HER2 overexpression or amplification has been proven to be a validated therapeutic target for HER2-positive gastric and gastroesophageal junction cancer (GC/GEJ) in ToGA trial. However, there is a huge unmet medical need in the HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77edb7bc2645b453b03a288b784ae44c
https://doi.org/10.1200/jco.2021.39.15_suppl.e16005
https://doi.org/10.1200/jco.2021.39.15_suppl.e16005
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND To determine the effects of dendritic cells (DCs) and cytokine-induced killer (CIK) cells in patients with malignant pericardial effusion. MATERIAL AND METHODS All patients underwent pericardial puncture and indwelling catheter insertion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9dbaa6c9aeed483c22323a83faaafb5
http://europepmc.org/articles/PMC5096661
http://europepmc.org/articles/PMC5096661